Segall Bryant & Hamill’s Idexx Laboratories IDXX Stock Holding History

Segall Bryant & Hamill’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,343	Closed	-$9.16M	–	606
2025 Q3	$9.16M	Sell	14,343 -6,743	-32%	-$4.09M	0.12%	249
2025 Q2	$11.3M	Buy	21,086 +2,140	+11%	+$1.02M	0.16%	207
2025 Q1	$7.96M	Sell	18,946 -1,856	-9%	-$806K	0.12%	249
2024 Q4	$8.6M	Buy	+20,802	New	+$9.12M	0.12%	249
2023 Q3	–	Sell	-9,610	Closed	-$4.83M	–	595
2023 Q2	$4.83M	Sell	9,610 -694	-7%	-$333K	0.05%	345
2023 Q1	$5.15M	Buy	10,304 +7	+0.1%	+$3.35K	0.06%	331
2022 Q4	$4.2M	Hold	10,297	–	–	0.05%	351
2022 Q3	$3.35M	Sell	10,297 -338	-3%	-$124K	0.04%	372
2022 Q2	$3.73M	Sell	10,635 -147	-1%	-$59.9K	0.04%	366
2022 Q1	$5.9M	Hold	10,782	–	–	0.06%	302
2021 Q4	$7.1M	Sell	10,782 -753	-7%	-$473K	0.07%	257
2021 Q3	$7.17M	Buy	11,535 +997	+9%	+$670K	0.07%	262
2021 Q2	$6.66M	Sell	10,538 -223	-2%	-$123K	0.06%	271
2021 Q1	$5.27M	Sell	10,761 -224	-2%	-$112K	0.05%	326
2020 Q4	$5.49M	Buy	10,985 +270	+3%	+$121K	0.06%	281
2020 Q3	$4.21M	Sell	10,715 -162	-1%	-$59.9K	0.06%	284
2020 Q2	$3.59M	Sell	10,877 -124	-1%	-$35.9K	0.06%	264
2020 Q1	$2.67M	Sell	11,001 -515	-4%	-$134K	0.05%	293
2019 Q4	$3.01M	Sell	11,516 -722	-6%	-$190K	0.05%	333
2019 Q3	$3.33M	Sell	12,238 -201	-2%	-$55.9K	0.05%	327
2019 Q2	$3.43M	Sell	12,439 -1,037	-8%	-$256K	0.05%	321
2019 Q1	$3.01M	Sell	13,476 -112	-0.8%	-$23.1K	0.05%	340
2018 Q4	$2.53M	Sell	13,588 -244	-2%	-$50K	0.04%	359
2018 Q3	$3.45M	Buy	13,832 +267	+2%	+$64.8K	0.05%	349
2018 Q2	$2.96M	Sell	13,565 -1,645	-11%	-$339K	0.05%	380
2018 Q1	$2.91M	Sell	15,210 -203	-1%	-$37.5K	0.07%	266
2017 Q4	$2.41M	Sell	15,413 -384	-2%	-$60.4K	0.05%	284
2017 Q3	$2.46M	Buy	15,797 +238	+2%	+$37.6K	0.06%	283
2017 Q2	$2.51M	Buy	15,559 +3,249	+26%	+$528K	0.06%	277
2017 Q1	$1.9M	Buy	12,310 +25	+0.2%	+$3.45K	0.05%	302
2016 Q4	$1.44M	Buy	12,285 +2,285	+23%	+$261K	0.04%	320
2016 Q3	$1.13M	Sell	10,000 -2,600	-21%	-$274K	0.03%	342
2016 Q2	$1.17M	Sell	12,600 -1,000	-7%	-$85.9K	0.03%	340
2016 Q1	$1.06M	Buy	13,600 +2,600	+24%	+$187K	0.03%	346
2015 Q4	$802K	Hold	11,000	–	–	0.02%	357
2015 Q3	$817K	Hold	11,000	–	–	0.02%	365
2015 Q2	$706K	Sell	11,000 -4,148	-27%	-$287K	0.02%	380
2015 Q1	$1.17M	Sell	15,148 -4	-0%	-$311	0.03%	332
2014 Q4	$1.12M	Buy	15,152 +4,152	+38%	+$291K	0.03%	340
2014 Q3	$648K	Buy	11,000 +2,000	+22%	+$126K	0.02%	398
2014 Q2	$601K	Buy	9,000 +4,000	+80%	+$254K	0.01%	408
2014 Q1	$304K	Hold	5,000	–	–	0.01%	514
2013 Q4	$266K	Sell	5,000 -2,000	-29%	-$105K	0.01%	529
2013 Q3	$349K	Buy	+7,000	New	+$336K	0.01%	486

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Segall Bryant & Hamill's IDXX Position: Q4 2025 in Review

Segall Bryant & Hamill sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 14,343 shares — an estimated $9.16M sold.

Segall Bryant & Hamill first reported a position in IDXX in Q3 2013 and held it in 44 quarters. The position peaked at $11.3M in Q2 2025. 1,385 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

Segall Bryant & Hamill reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
Segall Bryant & Hamill sold 14,343 Idexx Laboratories shares in Q4 2025, an estimated $9.16M.
Segall Bryant & Hamill first reported a position in Idexx Laboratories in Q3 2013 and held it in 44 quarters.
Segall Bryant & Hamill's Idexx Laboratories position peaked at $11.3M in Q2 2025.
1,385 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Segall Bryant & Hamill's 13F filing for Q4 2025, filed 13 Feb 2026.